Back to results
US 2012/0253046 A1Published application
Palonosetron metabolites
AssigneeHelsinn Healthcare SA
InventorWaldo Mossi
Life of this patent
Estimating the term…
Abstract
Provided are metabolites of palonosetron that can be used in treating animals, particularly humans, of the formula (I): or a pharmaceutically acceptable salt or prodrug thereof; wherein R1 and R4 independently can be H, hydroxyl, or carbonyl; and wherein R3 can be Formule (II) or Formule (III).
Claims10
1) An isolated compound of formula I:
- or a pharmaceutically acceptable salt thereof;
- wherein R1 and R4 independently are H, hydroxyl, or carbonyl;
- and
- wherein R3 is
1 more element
2) (canceled)
3) (canceled)
4) (canceled)
5) (canceled)
6) (canceled)
7) (canceled)
8) (canceled)
9) (canceled)
10) An isolated compound of formula II, III, IV, V, VI, VII, VIII or IX, or a pharmaceutically acceptable salt thereof:
Dependencies are inferred from the claim text.